<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="128071">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01434953</url>
  </required_header>
  <id_info>
    <org_study_id>AAAC6382</org_study_id>
    <nct_id>NCT01434953</nct_id>
  </id_info>
  <brief_title>Prehypertension Labeling</brief_title>
  <official_title>Diagnostic Labeling: Effect on White Coat Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Columbia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Columbia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to find out whether labeling adults with prehypertension has
      negative effects on clinic blood pressure and quality of life 3 months after diagnosis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">May 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood pressure</measure>
    <time_frame>Baseline, 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in health-related quality of life (SF-12 questionnaires)</measure>
    <time_frame>Baseline, 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Prehypertension</condition>
  <arm_group>
    <arm_group_label>Labeled</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Unlabeled</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Labeled prehypertension</intervention_name>
    <description>A study physician informs subjects of their blood pressure level. Subjects are told they have prehypertension and are informed of the associated health risks.</description>
    <arm_group_label>Labeled</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Unlabeled prehypertension</intervention_name>
    <description>A study physician informs subjects of their blood pressure level. The term &quot;prehypertension&quot; is not used and associated health risks are not discussed.</description>
    <arm_group_label>Unlabeled</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  at least 18 years

          -  average screening systolic blood pressure of 120-139 mmHg OR diastolic blood pressure
             of 80-89 mmHg

          -  average screening systolic blood pressure below 140 mmHg AND diastolic blood pressure
             below 90 mmHg

          -  able to read and write in English

        Exclusion Criteria:

          -  past diagnosis of hypertension, prehypertension, or high blood pressure

          -  current or past use of antihypertensive medications

          -  diabetes

          -  renal disease

          -  cardiovascular disease

          -  current participation in another hypertension-related clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tanya Goyal</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2011</verification_date>
  <lastchanged_date>September 14, 2011</lastchanged_date>
  <firstreceived_date>September 8, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prehypertension</keyword>
  <keyword>Blood pressure screening</keyword>
  <keyword>White coat effect</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Prehypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
